| Ibudilast for use in the treatment of post-covid conditions |
2023-1-31 |
2023-8-10 |
|
| Ibudilast in combination therapy for use in the treatment of glioblastoma |
2022-9-19 |
2023-3-30 |
|
| Methods of preventing cancer metastasis |
2022-7-25 |
2023-2-02 |
|
| Methods of minimizing cancer metastasis |
2022-7-25 |
2023-4-13 |
|
| Methods to decrease triglyceride synthesis in the liver |
2022-5-26 |
2022-12-08 |
|
| Methods of treating chemical gas exposure |
2022-1-27 |
2022-8-04 |
|
| Treatment of progressive neurodegenerative disease with ibudilast |
2021-7-02 |
2022-6-02 |
|
| Method for reducing plasma levels of macrophage migration inhibitory factor in … |
2021-4-05 |
2022-11-11 |
|
| Ibudilast oral formulations and methods of using same |
2020-9-21 |
2021-4-01 |
|
| Methods of suppressing myeloid-derived suppressor cells in patients |
2020-7-31 |
2021-6-17 |
|
| Methods and dosing regimens using ibudilast and a second agent for cancer … |
2020-7-10 |
2021-1-28 |
|
| Combination of ibudilast and riluzole and methods of using same |
2020-6-18 |
2021-1-07 |
|
| How to Treat Eye Diseases / Disorders or Injuries with Ibudilast |
2019-10-18 |
2022-1-14 |
|
| Combination of Ibudilast with Interferon-Beta and How to Use It |
2019-10-08 |
2022-1-13 |
|
| Methods for treating hepatic disorders |
2019-8-23 |
2019-12-26 |
|
| Method of treating non-alcoholic fatty liver disease and non-alcoholic … |
2019-8-02 |
2019-10-24 |
|
| Methods of treating glioblastoma multiforme using ibudilast |
2019-7-09 |
2020-2-06 |
|
| Compositions for inhibiting or treating scleroderma/systemic sclerosis |
2018-9-07 |
2019-1-10 |
|
| Method of treating idiopathic pulmonary fibrosis |
2017-7-05 |
2018-1-25 |
|
| Treatment of alcoholism and depression through the use of ibudilast |
2017-5-09 |
2022-7-11 |
2022-7-11 |
| Ibudilast and telmisartan for treating non-alcoholic fatty liver disease, non … |
2015-11-24 |
2016-6-02 |
|
| A combination of geranygeranylacetone, ibudilast, and riluzole and methods of … |
2015-11-24 |
2016-6-02 |
|
| Method of inhibiting or treating fibrosis |
2015-11-24 |
2016-6-02 |
|
| Geranygeranylacetone and analogs thereof and phenoxyalkylcarboxlic acids for … |
2015-11-24 |
2016-6-02 |
|
| A combination of geranylgeranylacetone and ibudilast and methods of using same |
2015-6-17 |
2015-12-23 |
|
| Method of inhibiting or treating amyotrophic lateral sclerosis with … |
2015-5-06 |
2015-11-12 |
|
| Treatment of advanced non-alcoholic steatohepatitis |
2015-5-06 |
2020-3-25 |
2020-3-25 |
| Methods for reducing triglyceride, total cholesterol and low density … |
2014-11-13 |
2015-3-19 |
|
| Treatment of alcoholism using ibudilast |
2014-8-14 |
2015-2-19 |
|
| Polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio) … |
2013-12-24 |
2014-5-29 |
|
| Denibulin di-hydrochloride |
2013-10-14 |
2014-2-13 |
|
| Methods for compositions for the treatment of irritable bowel syndrome |
2013-8-26 |
2014-3-06 |
|
| SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUND AND ITS METHOD OF USE |
2013-7-03 |
2013-9-26 |
|
| Treatment of acute exacerbation of asthma and reduction of likelihood of … |
2013-3-07 |
2014-2-27 |
|
| Ibudilast for relieving negative effects of medication overuse headache |
2012-12-12 |
2013-7-11 |
|
| Ibudilast for relieving negative effects of medication overuse headache |
2012-3-16 |
2013-6-15 |
|
| Treating human male copd patients with oral bedoradrine |
2012-2-21 |
2012-11-22 |
|
| Method for treating drug and behavioral addictions |
2011-3-28 |
2011-11-10 |
|
| Compositions, methods, and devices for the treatment of dysmenorrhea |
2011-3-08 |
2011-11-01 |
|
| Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl) … |
2010-6-23 |
2011-1-16 |
|
| Substituted pyrazolo[1,5-a]pyridine compounds having multi-target activity |
2010-6-08 |
2011-1-16 |
|
| Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel … |
2010-5-07 |
2010-11-11 |
|
| Ibudilast and immunomodulators combination |
2010-4-07 |
2010-10-14 |
|
| Method for antagonizing MIF activity |
2009-5-07 |
2009-9-03 |
|
| Method for treating neuropathic pain and associated syndromes |
2009-4-17 |
2009-8-20 |
|
| Treatment of depression, psychosis, and anxiety |
2008-7-22 |
2009-1-29 |
|
| The polymorphic form A of 4-[6-acetyl-3[3-(4-acetyl-3-hydroxy-2- … |
2008-7-09 |
2008-7-31 |
|
| Use of a glial attenuator to prevent amplified pain responses caused by glial … |
2008-5-01 |
2008-11-20 |
|
| Methods for treating acute and subchronic pain |
2008-1-29 |
2008-7-31 |
|
| Method of treatment or prophylaxis of depression |
2007-8-22 |
2008-6-16 |
|
| MIF inhibitors for treating neuropathic pain and associated syndromes |
2007-5-29 |
2007-12-06 |
|
| Method for treating drug and behavioral addictions |
2006-9-26 |
2007-3-29 |
|
| Topical treatment of solid tumors and ocular neovascularization |
2006-1-11 |
2006-7-20 |
|
| Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2 … |
2005-12-22 |
2006-5-18 |
|